Display options
Cite
Karnezis AN, Leung S, Magrill J, et al. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. J Pathol Clin Res. 2017;3(4):279-293doi: 10.1002/cjp2.82.
Karnezis, A. N., Leung, S., Magrill, J., McConechy, M. K., Yang, W., Chow, C., Kobel, M., Lee, C. H., Huntsman, D. G., Talhouk, A., Kommoss, F., Gilks, C. B., & McAlpine, J. N. (2017). Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. The journal of pathology. Clinical research, 3(4), 279-293. https://doi.org/10.1002/cjp2.82
Karnezis, Anthony N, et al. "Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification." The journal of pathology. Clinical research vol. 3,4 (2017): 279-293. doi: https://doi.org/10.1002/cjp2.82
Karnezis AN, Leung S, Magrill J, McConechy MK, Yang W, Chow C, Kobel M, Lee CH, Huntsman DG, Talhouk A, Kommoss F, Gilks CB, McAlpine JN. Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification. J Pathol Clin Res. 2017 Oct 14;3(4):279-293. doi: 10.1002/cjp2.82. eCollection 2017 Oct. PMID: 29085668; PMCID: PMC5653931.
Copy Download .nbib Format: NLM
Share it on

J Pathol Clin Res. 2017 Oct 14;3(4):279-293. doi: 10.1002/cjp2.82. eCollection 2017 Oct.

Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification.

The journal of pathology. Clinical research

Anthony N Karnezis, Samuel Leung, Jamie Magrill, Melissa K McConechy, Winnie Yang, Christine Chow, Martin Kobel, Cheng-Han Lee, David G Huntsman, Aline Talhouk, Friederich Kommoss, C Blake Gilks, Jessica N McAlpine

Affiliations

  1. Department of Pathology and Laboratory MedicineUniversity of British ColumbiaVancouverBCCanada.
  2. BC Cancer AgencyVancouverBCCanada.
  3. Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation CentreUniversity of British ColumbiaVancouverBCCanada.
  4. Department of Human GeneticsMcGill University, Research Institute of the McGill University Health NetworkMontrealQCCanada.
  5. Department of PathologyTom Baker Cancer CenterCalgaryABCanada.
  6. Department of Gynecology and Obstetrics, Division of Gynecologic OncologyUniversity of British ColumbiaVancouverBCCanada.

PMID: 29085668 PMCID: PMC5653931 DOI: 10.1002/cjp2.82

Abstract

Molecular subclassification of endometrial carcinoma (EC) with Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) identifies four subtypes [DNA polymerase epsilon (

Keywords: L1CAM; ProMisE; TCGA; biomarker; endometrial cancer; estrogen receptor; progesterone receptor; prognosis

References

  1. Int J Cancer. 2015 Mar 1;136(5):E359-86 - PubMed
  2. Nature. 2013 Oct 17;502(7471):333-339 - PubMed
  3. Gynecol Oncol. 2016 Jun;141(3):559-563 - PubMed
  4. J Cancer Res Clin Oncol. 2017 Feb;143(2):255-262 - PubMed
  5. Am J Surg Pathol. 2013 Jun;37(6):874-81 - PubMed
  6. Cancer. 2017 Mar 1;123(5):802-813 - PubMed
  7. Eur J Cancer. 2014 Oct;50(15):2602-10 - PubMed
  8. Gynecol Oncol. 2017 Aug;146(2):247-253 - PubMed
  9. Clin Cancer Res. 2016 Jun 15;22(12):2865-73 - PubMed
  10. Int J Gynecol Cancer. 2016 Jan;26(1):2-30 - PubMed
  11. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12 ):4834-9 - PubMed
  12. PLoS One. 2014 Feb 25;9(2):e90141 - PubMed
  13. Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):375-82 - PubMed
  14. Mod Pathol. 2012 May;25(5):699-708 - PubMed
  15. Clin Cancer Res. 2013 May 1;19(9):2331-41 - PubMed
  16. Mod Pathol. 2005 May;18(5):719-27 - PubMed
  17. Clin Cancer Res. 2016 Aug 15;22(16):4215-24 - PubMed
  18. Histopathology. 2010 Oct;57(4):641-6 - PubMed
  19. Anticancer Res. 2009 May;29(5):1585-90 - PubMed
  20. Gynecol Oncol. 2009 Mar;112(3):537-42 - PubMed
  21. Nat Rev Clin Oncol. 2011 May;8(5):302-6 - PubMed
  22. Br J Cancer. 2015 Jul 14;113(2):299-310 - PubMed
  23. Clin Cancer Res. 2011 May 15;17(10):3368-77 - PubMed
  24. Cancer Res. 2001 Jun 1;61(11):4311-4 - PubMed
  25. World J Surg Oncol. 2015 Jun 25;13:208 - PubMed
  26. Gynecol Oncol. 2017 Oct;147(1):158-166 - PubMed
  27. Mod Pathol. 2013 Dec;26(12):1594-604 - PubMed
  28. Gynecol Oncol. 2016 Jul;142(1):62-69 - PubMed
  29. Mod Pathol. 2016 Feb;29(2):174-81 - PubMed
  30. Mod Pathol. 2015 Jun;28(6):836-44 - PubMed
  31. Sci Transl Med. 2010 Oct 13;2(53):53ra75 - PubMed
  32. Int J Cancer. 2005 Jul 1;115(4):658-65 - PubMed
  33. Ann Oncol. 2013 Oct;24 Suppl 6:vi33-8 - PubMed
  34. Arch Pathol Lab Med. 2014 Aug;138(8):1027-36 - PubMed
  35. Gynecol Oncol. 2016 Oct;143(1):46-53 - PubMed
  36. Mol Oncol. 2015 Oct;9(8):1694-703 - PubMed
  37. J Cell Biol. 2001 Nov 12;155(4):661-73 - PubMed
  38. Gynecol Oncol. 2016 May;141(2):336-340 - PubMed
  39. Eur J Cancer. 2013 Nov;49(16):3431-41 - PubMed
  40. Oncotarget. 2017 Jan 3;8(1):506-511 - PubMed
  41. Br J Cancer. 2015 Mar 3;112(5):793-801 - PubMed
  42. J Natl Cancer Inst. 2013 Aug 7;105(15):1142-50 - PubMed
  43. Mod Pathol. 2007 Nov;20(11):1156-65 - PubMed

Publication Types